Experimental cancer combo study halted after just 3 patients
Disease control
Terminated
This study tested a new drug called CX-072 combined with other cancer treatments for adults with solid tumors or advanced melanoma. The goal was to see if the combination shrank tumors. However, the study was stopped early and only enrolled 3 people, so no clear results are avail…
Phase: PHASE2 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC